PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a clinical-stage biopharmaceutical company ...

Seaport Therapeutics announced that Bob Hombach has been appointed to its Board of Directors and will serve as the Chair of ...

China and Mexico are two of the largest medical equipment manufacturers in the world. The U.S. has imported roughly $10B in medical equipment from China, so far this year, and about $7B from Mexico, ...

Becton, Dickinson and Company has a 12 month low of $218.75 and a 12 month high of $251.99. The stock has a 50 day moving average of $233.08 and a two-hundred day moving average of $233.02.

Viewing insider transactions for Embecta Corp.'s (NASDAQ:EMBC ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in ...

Investors in Becton, Dickinson & Co (Symbol: BDX) saw new options begin trading today, for the December 2026 expiration. One of the key data points that goes into the price an option buyer is ...

The global Cancer Biomarkers Market is expected to grow at 12.7% CAGR from 2025 to 2032. Latest Research Report on the Cancer Biomarkers Market Size, Status, and Forecast for 2025-2032. In-depth ...

Former Jets first-round pick Mekhi Becton was a washout at tackle before resuscitating his career with a move to guard. Becton started for the Eagles in 2024, won a Super Bowl and is likely to ...

Fortunately, it did not take Mr Chiang long to land a new job as the business director for South-east Asia at US medical technology firm Becton, Dickinson ... his way up. Embecta was spun off ...